Human body needs three requisites for its smooth functioning and existence - Oxygen, Water and Food in that order.
At macro level, as we see in the recent times, Indian pharma market has achieved a significant growth of approx. 17% in the current year. This eventually indicates a similar growth in the use of Sterile Water for Injections (SWFI) and Sterile Water for Reconstitution (SWFR) by the top players in the Anti-infective therapeutic segment. Cipla grew by 25% followed by Macleods at 18.9% followed by Sun Pharmaceuticals and Alkem. Lupin's Monocef, where SWFI is primarily used has registered a substantial growth of 36.6% which is a broad indicator of scope of "Water For Injection". SunLife is a GMP / GLP certified and is recently granted WHO-GMP for our quality systems and compliance. to meet the global demand for quality products. In this small period of few months of institution, SunLife has successfully made its unique positioning in WFI segment and today it is a well acclaimed brand amongst the SVP Diluents . From earlier trend, presently we have drastically reduced our exposure in the trading and the focus remains in B2B segment direct with the leading pharma companies on Rate contract and Quantity contract basis. Over the period, SunLife has been audited and approved by various top ranking companies and today we are the preferred supplier of SWFI and SWFR.
I can assure that we are doing everything possible to do business in most transparent and ethical way with quality in the focus.
Dr. S.S. Juss
President (Sales & Marketing)
Awards & Recognition
- Financial Result
- Notices/ Results
- He Times of India covers "Promote Soccer For A Beautiful Future"...
- Annual Report 2013
- Investor Relations Presentation